Kevin Kratiuk Selected Research

Anhedonia

1/2022	Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation.
11/2020	Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of Excellence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kevin Kratiuk Research Topics

Disease

23	Treatment-Resistant Depressive Disorder 02/2024 - 02/2019
10	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 01/2020
9	Major Depressive Disorder (Major Depressive Disorders) 10/2022 - 02/2019
7	Mood Disorders (Mood Disorder) 01/2022 - 12/2020
2	Anhedonia 01/2022 - 11/2020
1	Borderline Personality Disorder (Personality Disorders, Borderline) 01/2023
1	Neurobehavioral Manifestations 10/2022
1	Psychomotor Agitation (Akathisia) 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Inflammation (Inflammations) 04/2021
1	Hematuria 04/2021
1	Dysuria 04/2021
1	Headache (Headaches) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Nausea 01/2021
1	COVID-19 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 08/2020
1	Mania (Manias) 08/2020

Drug/Important Bio-Agent (IBA)

24	Ketamine FDA LinkGeneric 01/2023 - 01/2020
10	Antidepressive Agents (Antidepressants)IBA 10/2022 - 02/2019
3	EsketamineIBA 04/2021 - 01/2021
1	Psilocybin (Psilocibin)IBA 02/2024
1	Immunoglobulin E (IgE)IBA 04/2021
1	Anesthetics (Anesthetic Agents)IBA 04/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	GLYX-13 peptideIBA 02/2019
1	N-Methylaspartate (NMDA)IBA 02/2019